Clinical Trial Update: Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating donor T cell therapy for adenoviral infection in immunocompromised patients with hematologic malignancies. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoviral Infection
• Hematologic Malignancy

Drugs mentioned

• Donor T Cell Therapy

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Immunocompromised | Phase 1 | Status: RECRUITING